Chronic ethanol (EtOH) exposure produces neuroadaptations within the NMDA receptor system and alterations in HPA axis functioning that contribute to neurodegeneration during ethanol withdrawal (EWD). Chronic EtOH exposure and EWD, as well as corticosteroids, also promote increased synthesis and release of polyamines, which allosterically potentiate NMDA receptor open-channel time at the NR2B subunit. The current studies investigated effects of 10 day EtOH and corticosterone (CORT) co-exposure on toxicity during EWD in rat organotypic hippocampal slice cultures, and alterations in function and/or density of the NR2B subunit of the NMDA receptor that may mediate CORT-potentiation of toxicity during EWD. We hypothesized that toxicity during withdrawal following EtOH and CORT co-exposure would be greatest in the CA1 region due to increased NMDA NR2B receptor abundance and/or function. Cultures were exposed to CORT (0.01–1 μM) during 10 day EtOH exposure (50 mM) and 1 day EWD. Additional EtOH-naïve cultures were exposed to CORT for 11 days. Propidium iodide (PI) was used to measure toxicity in the CA1, CA3, and DG hippocampal regions. In EtOH-naïve cultures, 11 day exposure to CORT (0.01 – 1 μM) produced modest toxicity and in all regions. Exposure to CORT during EtOH exposure/EWD potentiated CORT-toxicity at all concentrations in the CA1 region. Ifenprodil, an NR2B polyamine site antagonist, significantly reduced toxicity from EtOH and CORT (0.1 μM) co-exposure during withdrawal. Immunohistochemistry and Western blot analyses were conducted for measurement of NR2B immunoreactivity in organotypic cultures, and autoradiography studies were conducted for measurement of polyamine-sensitive NR2B subunits with [3H]ifenprodil. Consistent increases in NR2B subunit protein were not detected with use of any methodology. Additional studies exposed cultures to a membrane impermeable form of CORT (BSA-conjugated CORT; 0.1 μM) with or without EtOH exposure and withdrawal. BSA-CORT exposure did not produce toxicity in any hippocampal region, suggesting that CORT toxicity was not mediated by membrane bound substrates. These data suggest that CORT and EtOH co-exposure result in increased function of polyamine-sensitive NR2B subunits, but this toxicity does not appear dependent on the number of hippocampal NMDA NR2B subunits.

Exposure to ethanol (ETOH) during fetal development results in a range of cognitive/behavioral deficits. There are differences in sensitivity to the effects of ETOH that could be explained by other factors, such as hypoxia. Similar mechanisms of damage underlie both ETOH, more specifically ETOH withdrawal, and hypoxia. Based on this overlap, it was hypothesized that sub threshold levels of these insults may interact to produce increased damage in sensitive brain regions. This study used a rodent organotypic hippocampal slice culture model to investigate the interaction of hypoxia and ETOH withdrawal and to determine possible developmental differences in the sensitivity to these insults. The combination of ETOH and hypoxia produced greater damage in the CA1 and CA3 hippocampal regions, as measured by propidium iodide uptake. Differences in outcome were noted between on postnatal (PND) 2 and PND 8 tissue. ETOH alone caused damage as measured by the neuronal marker NeuN, suggesting the ETOH/hypoxia interaction involves different cell types and that caution should be taken when determining appropriate levels of exposure. This data could explain why some offspring appear more sensitive to ETOH and/or hypoxic challenges during early life.

Alcohol abuse disorders (AUD) represent a serious worldwide health problem with far reaching social, financial, and interpersonal implications. One of the most devastating facets of these disorders is the propensity to relapse following periods of abstinence. Ethanol withdrawal (EWD) is believed to promote relapse by increasing anxiety and craving, and may contribute to the development of cognitive decline associated with long-term dependence. Clinical data suggest that stress also plays a main role in both the development of AUD as well as relapse to drinking. As a physiological stressor, EtOH elevates levels of stress hormones (cortisol in humans, corticosterone (CORT) in the rat). Both CORT and EtOH have been shown to alter the composition, function, and activity of the N-methyl-D-aspartate (NMDA) receptor, and in particular, the NR2B subunit of this receptor. These alterations have been suggested to mediate EWD, which may negatively impact abstinence rates. This synergistic interaction between EtOH and CORT may present a therapeutic target for the treatment of EWD. In fact, data suggest that blocking the glucocorticoid receptor, which is a main target for CORT, with RU-486 could promote abstinence, as treatment with the drug has been shown to reduce consumption and the development dependence, as well as the severity of EWD and the cognitive deficits following EWD. However, these latter effects have not been validated in models of voluntary EtOH consumption. As there is considerable evidence that active versus passive intake can significantly impact neuroadaptations to ethanol this is an important consideration. These studies sought to characterize consumption and evaluate the development of dependence in a chronic voluntary model of intermittent access (IA) to EtOH. CORT plasma levels and protein expression of the glucocorticoid and NR2B receptors were measured during and/or following exposure. Finally, to assess the role of CORT in EtOH consumption and the development of dependence, the glucocorticoid receptor antagonist ORG-34517 was administered during access to EtOH. IA access to 20% EtOH produced varying levels of consumption (2.0-6.7g/kg/24hr exposure) and blood EtOH levels (6.3-116.9 mg/dl), but did not significantly affect food consumption or weight gain. Baseline CORT levels were found to be predictive of subsequent EtOH consumption and levels of consumption were sufficient to elevate CORT levels following one hour of EtOH exposure. Further, IA to EtOH was sufficient to produce dependence, as measured by elevations in the acoustic startle reflex following 26 hours and five days of withdrawal. No alteration in protein expression was observed regarding either the NR2B or glucocorticoid receptors and exposure to ORG-34517 had no effect on consumption or withdrawal.

A abstinência ao etanol está associada ao transtorno de ansiedade. Várias estruturas e sistemas de neurotransmissores estão envolvidos na mediação deste efeito, entretanto, tais substratos ainda não foram completamente elucidados. Em modelos animais, estudos mostram aumento significativo da neurotransmissão nitrérgica em resposta à abstinência do consumo crônico de etanol. O Núcleo Dorsal da Rafe (NDR) é uma importante região envolvida na gênese da ansiedade e possui grande quantidade da isoforma neuronial da enzima Sintase do Óxido Nítrico (nNOS). Assim, o objetivo deste estudo foi verificar se a inibição da transmissão nitrérgica no NDR atenua os efeitos ansiogênicos induzidos pela abstinência do etanol. Com essa finalidade, ratos Wistar machos foram submetidos a tratamento crônico (21 dias) ou agudo (1 dia) com etanol 6%(v/v) seguido da suspensão abrupta do tratamento por 48hs. Após as 48hrs os animais receberam uma injeção intra-NDR de L-NAME (100nmoles/0,2µL; inibidor não seletivo da NOS) ou 7-NI (7-Nitro-Indazol; 5 nmoles/0,2µL; inibidor seletivo para nNOS) e 5 min. depois foram testados no Labirinto em Cruz Elevado (LCE). Em resumo, os dados mostraram que a abstinência de 48hs. do tratamento crônico com etanol promoveu efeitos ansiogênicos significativos, evidenciados pela redução do número de entradas e tempo gasto nos braços abertos do LCE, o qual foi atenuado pelo tratamento intra-NDR com L-NAME mas não com 7-NI, sugerindo o envolvimento do NO no NDR na ansiedade induzida pela abstinência do etanol / The ethanol withdrawal is linked to the disorder of anxiety. Several structures and neurotransmitter systems are involved in mediating this effect, however, such substrates have not yet been elucidated. In animal models, studies show significant increase in neurotransmission nitrérgica in response to abstinence from chronic consumption of ethanol. The Dorsal Raphe Nucleus (DNR) is an important region involved in the genesis of anxiety and has large amounts of the enzyme Sintase neuronial isoform of nitric oxide (nNOS). The aim of this study was to verify that the inhibition of transmission in the DNR nitrérgica attenuates the anxiogenic effects induced by ethanol withdrawal. For this purpose, male Wistar rats were subjected to chronic treatment (21 days) or acute (1 day) with 6% ethanol (v / v) followed by the abrupt suspension of treatment for 48 hours. 48hrs after the animals received an intra-DNR L-NAME (100nmoles / 0.2 L, non-selective inhibitor of NOS) or 7-NI (7-Nitro-indazol, 5 nmol / 0,2 L; selective inhibitor for nNOS ) and 5 min. then were tested in the elevated plus-maze (EPM). Data obtained showed that ethanol withdrawal elicited significant \"anxiety-like\" behaviors, as revealed by the decrease in the number of entries into and time spent onto the open arms of the EPM., which was attenuated by treatment with intra-DNR L-NAME but not with 7-NI. These findings are indicative of the involvement of the DNR \"anxiety-like\" behaviors induced by withdrawal of ethanol.

A abstinência ao etanol está associada ao transtorno de ansiedade. Várias estruturas e sistemas de neurotransmissores estão envolvidos na mediação deste efeito, entretanto, tais substratos ainda não foram completamente elucidados. Em modelos animais, estudos mostram aumento significativo da neurotransmissão nitrérgica em resposta à abstinência do consumo crônico de etanol. O Núcleo Dorsal da Rafe (NDR) é uma importante região envolvida na gênese da ansiedade e possui grande quantidade da isoforma neuronial da enzima Sintase do Óxido Nítrico (nNOS). Assim, o objetivo deste estudo foi verificar se a inibição da transmissão nitrérgica no NDR atenua os efeitos ansiogênicos induzidos pela abstinência do etanol. Com essa finalidade, ratos Wistar machos foram submetidos a tratamento crônico (21 dias) ou agudo (1 dia) com etanol 6%(v/v) seguido da suspensão abrupta do tratamento por 48hs. Após as 48hrs os animais receberam uma injeção intra-NDR de L-NAME (100nmoles/0,2µL; inibidor não seletivo da NOS) ou 7-NI (7-Nitro-Indazol; 5 nmoles/0,2µL; inibidor seletivo para nNOS) e 5 min. depois foram testados no Labirinto em Cruz Elevado (LCE). Em resumo, os dados mostraram que a abstinência de 48hs. do tratamento crônico com etanol promoveu efeitos ansiogênicos significativos, evidenciados pela redução do número de entradas e tempo gasto nos braços abertos do LCE, o qual foi atenuado pelo tratamento intra-NDR com L-NAME mas não com 7-NI, sugerindo o envolvimento do NO no NDR na ansiedade induzida pela abstinência do etanol / The ethanol withdrawal is linked to the disorder of anxiety. Several structures and neurotransmitter systems are involved in mediating this effect, however, such substrates have not yet been elucidated. In animal models, studies show significant increase in neurotransmission nitrérgica in response to abstinence from chronic consumption of ethanol. The Dorsal Raphe Nucleus (DNR) is an important region involved in the genesis of anxiety and has large amounts of the enzyme Sintase neuronial isoform of nitric oxide (nNOS). The aim of this study was to verify that the inhibition of transmission in the DNR nitrérgica attenuates the anxiogenic effects induced by ethanol withdrawal. For this purpose, male Wistar rats were subjected to chronic treatment (21 days) or acute (1 day) with 6% ethanol (v / v) followed by the abrupt suspension of treatment for 48 hours. 48hrs after the animals received an intra-DNR L-NAME (100nmoles / 0.2 L, non-selective inhibitor of NOS) or 7-NI (7-Nitro-indazol, 5 nmol / 0,2 L; selective inhibitor for nNOS ) and 5 min. then were tested in the elevated plus-maze (EPM). Data obtained showed that ethanol withdrawal elicited significant \"anxiety-like\" behaviors, as revealed by the decrease in the number of entries into and time spent onto the open arms of the EPM., which was attenuated by treatment with intra-DNR L-NAME but not with 7-NI. These findings are indicative of the involvement of the DNR \"anxiety-like\" behaviors induced by withdrawal of ethanol.